Therapeutic Advances in Cardiovascular Disease

Aims & Scope

Therapeutic Advances in Cardiovascular Disease delivers the highest quality peer-reviewed open access original research articles, reviews, and scholarly comment on pioneering efforts and innovative studies in the medical treatment of cardiac and circulatory conditions.

The journal has a strong clinical and pharmacological focus and is aimed at an international audience of clinicians and researchers in cardiology, circulatory disorders and related disciplines, providing an online forum for rapid dissemination of recent research and perspectives in this area.

Metrics & Ranking

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Directory of Open Access Journals (DOAJ)
• Web of Science
• Medline
• PubMed
• Embase

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

Licensing & Copyright

This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.

Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.

Policy Links

This section provides access to essential policy documents, guidelines, and resources related to the journal’s publication and submission processes.

• Aims scope
• Homepage
• Oa statement
• Author instructions
• License terms
• Review url
• Board url
• Plagiarism url
• Preservation url
• Apc url
• License

Plagiarism Policy

This journal follows a plagiarism policy. All submitted manuscripts are screened using reliable plagiarism detection software to ensure originality and academic integrity. Authors are responsible for proper citation and acknowledgment of all sources, and any form of plagiarism, including self-plagiarism, will not be tolerated.

For more details, please refer to our official: Plagiarism Policy.

APC Details

The journal’s Article Processing Charge (APC) policies support open access publishing in Medicine, ensuring accessibility and quality in research dissemination.

This journal requires an Article Processing Charge (APC) to support open access publishing, covering peer review, editing, and distribution. The current APC is 2,650.00 USD. Learn more.

Explore journals without APCs for alternative publishing options.

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Metabolic syndrome: pathophysiology, management, and modulation by natural compounds

  Citation: 788

  Authors: Yogita, Naga Venkata, Swathi, Jawahar L.

• 6-minute walking test: a useful tool in the management of heart failure patients

  Citation: 248

  Authors: Sophia, Mara, Aris, Anna, Lampros K., Katerina K.

• Review: Preeclampsia and future cardiovascular risk: formal risk factor or failed stress test?

  Citation: 142

  Authors: Iasmina, Steven, Vesna D.

• Challenges in management of left ventricular thrombus

  Citation: 123

  Authors: Fuad, Srikanth

• ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension

  Citation: 122

  Authors: Evelyn, Alejandra, David, Andrés, Pablo F., Jorge E., Mario, Sergio, María Paz

• Cardiac remodelling and RAS inhibition

  Citation: 101

  Authors: Carlos M.

• The emerging role of endothelin-1 in the pathogenesis of pre-eclampsia

  Citation: 98

  Authors: Langeza, Koen, Willy, Anton H., A. H. Jan

• Mechanisms of alcoholic heart disease

  Citation: 90

  Authors: Jun, Loren E.

• Review: Role of the augmentation index in hypertension

  Citation: 82

  Authors: Motohiro, Kazuomi

• Original Research: Carotid intima-media thickness and plaque volume changes following 2-year angiotensin II-receptor blockade. The Multicentre Olmesartan atherosclerosis Regression Evaluation (MORE) study

  Citation: 81

  Authors: Klaus O., Enrico, Tomasz, Dieter, Jürgen, Petra, Peter, Malte